These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use. Garrouste-Orgeas M; Timsit JF; Kallel H; Ben Ali A; Dumay MF; Paoli B; Misset B; Carlet J Infect Control Hosp Epidemiol; 2001 Nov; 22(11):687-92. PubMed ID: 11842988 [TBL] [Abstract][Full Text] [Related]
3. [Do glycopeptides remain the preferred treatment of nosocomial infections from multidrug resistant Staphylococcus?]. Brun-Buisson C Med Mal Infect; 2004 Sep; 34 Suppl 2():S184-7. PubMed ID: 15620801 [No Abstract] [Full Text] [Related]
4. Methicillin-resistant Staphylococcus aureus: the persistent resistant nosocomial pathogen. Martin MA Curr Clin Top Infect Dis; 1994; 14():170-91. PubMed ID: 8086114 [TBL] [Abstract][Full Text] [Related]
5. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms. Henderson DK Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S46-54: discussion S64-73. PubMed ID: 16813982 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance of community and hospital acquired Staphylococcus aureus isolates to oxacillin and glycopeptides. Anwar MS; Bokhari SR J Coll Physicians Surg Pak; 2003 Jan; 13(1):33-6. PubMed ID: 12685973 [TBL] [Abstract][Full Text] [Related]
7. MRSA and MRSE: is there an answer? Carbon C Clin Microbiol Infect; 2000 Aug; 6 Suppl 2():17-22. PubMed ID: 11523520 [No Abstract] [Full Text] [Related]
8. Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models. Austin DJ; Anderson RM Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):721-38. PubMed ID: 10365398 [TBL] [Abstract][Full Text] [Related]
9. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Appelbaum PC Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():16-23. PubMed ID: 16445720 [TBL] [Abstract][Full Text] [Related]
10. Glycopeptides in the treatment of staphylococcal infections. Daschner FD; Kropec A Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S12-7. PubMed ID: 7729466 [TBL] [Abstract][Full Text] [Related]
11. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Stein GE; Wells EM Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750 [TBL] [Abstract][Full Text] [Related]
12. [Nasal carriage of meticillin-resistant Staphylococcus aureus among health care personnel in Abidjan (Côte d'lvoire)]. Akoua Koffi C; Dje K; Toure R; Guessennd N; Acho B; Faye Kette H; Loukou YG; Dosso M Dakar Med; 2004; 49(1):70-4. PubMed ID: 15782482 [TBL] [Abstract][Full Text] [Related]
13. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469 [TBL] [Abstract][Full Text] [Related]
14. [Profile of patients facing therapeutic problems in nosocomial infections due to methicillin-resistant staphylococci--A survey of practices]. Sollet JP; Gauzit R Ann Fr Anesth Reanim; 2002 May; 21(5):410-3. PubMed ID: 12078435 [TBL] [Abstract][Full Text] [Related]
15. In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillin-resistant staphylococci. Bergeret M; Boutros N; Raymond J Int J Antimicrob Agents; 2004 Mar; 23(3):247-53. PubMed ID: 15164965 [TBL] [Abstract][Full Text] [Related]
17. MRSA: Pandora's box for hospitals. Shovein J; Young MS Am J Nurs; 1992 Feb; 92(2):48-52. PubMed ID: 1739114 [No Abstract] [Full Text] [Related]
18. [Searching for Staphylococcus aureus strains with reduced susceptibility to glycopeptides among clinical isolates obtained during the year of 2002]. Młynarczyk A; Młynarczyk G; Łuczak M Med Dosw Mikrobiol; 2003; 55(3):209-17. PubMed ID: 14702662 [TBL] [Abstract][Full Text] [Related]